IBI Group Inc. announced the appointment of Angela Holtham, FCPA, FCMA, ICD.D. to its Board of Directors. Ms. Holtham brings to the Board thirteen years of experience as chief financial officer at The Hospital for Sick Children and Nabisco Ltd.Canada. In these positions she was responsible for overseeing traditional finance functions including internal audit, capital planning, and managing debt and working capital.

In addition to IBI Group, Ms. Holtham serves on a number of public and non-profit Boards. She is currently a Director and Chair of the Audit and Risk Management Committee of the Ontario Financing Authority and a Director and Chair of the Audit Committee of Oncolytics Biotech Inc.